# A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye

> **NCT05201170** · PHASE3 · COMPLETED · sponsor: **Palatin Technologies, Inc** · enrollment: 575 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Syndromes

## Interventions

- **DRUG:** Vehicle Ophthalmic Solution
- **DRUG:** PL9643 Ophthalmic Solution

## Key facts

- **NCT ID:** NCT05201170
- **Lead sponsor:** Palatin Technologies, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-30
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-11-21
- **Target enrollment:** 575 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05201170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05201170, "A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05201170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*